You just read:

ImmunoCellular Therapeutics Announces Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO 2017

News provided by

ImmunoCellular Therapeutics, Ltd.

05 Jun, 2017, 16:05 ET